Largest Alzheimer’s Genetics Study Finds 48 New Risk Regions and Points to Immune Pathways
November 15, 2026
Published in Nature Neuroscience on October 28, the study is described as the largest genetic association study of Alzheimer’s disease to date.
Led by Vrije Universiteit Amsterdam, researchers combined data from 30 cohorts, including more than 109,000 people diagnosed with Alzheimer’s and about 74,000 people whose parents had the disease, and analyzed genetic data from more than 2.8 million people.
The analysis identified 127 DNA regions associated with Alzheimer’s, including 48 not previously linked to the disease.
The findings reinforce the role of immune processes and point to more specific mechanisms involving microglia and other nerve cells.
The implicated biological pathways also include fat binding, cell adhesion, amyloid clearance, oxidative-stress regulation and membrane recycling at nerve junctions.
Brain-cell data linked inherited risk to higher activity of genes in microglia and broadly lower gene activity in neurons, though researchers could not tell whether the neuronal dampening is an early cause or a consequence of Alzheimer’s.
The researchers prioritized 17 genes in newly identified regions that interact with drugs approved for other conditions, and highlighted QPCT, which modifies amyloid-beta, as well as a region involving UBE2V1 and SPATA2 that shares a likely causal variant with amyotrophic lateral sclerosis.
Researchers said the newly identified regions could offer clues to how Alzheimer’s develops and potential targets for future drug research, but genetic associations and drug-database matches do not show that targeting a gene will prevent or treat the disease.
A polygenic score based on many variants explained nearly 13% of susceptibility variation in held-out European cohorts; among UK Biobank participants aged 65 and older, Alzheimer’s prevalence was seven times higher in the top 10% of scores than in the bottom 10%.
For people of European ancestry, common variants accounted for an estimated 16% of population differences in underlying Alzheimer’s susceptibility, nearly triple an older estimate of 6%, while estimates for African-ancestry participants were not statistically significant because of smaller samples and other limitations.
Genetic risk overlapped closely between men and women, although the APOE ε4 variant’s association with Alzheimer’s was about 13% stronger in women.
The study’s predominantly European-ancestry sample limited discovery in other groups and made risk scores less accurate in African and East Asian cohorts; many cases, especially outside European-ancestry groups, were identified through reports of a parent’s dementia rather than clinical diagnosis.
Summary based on 2 sources
Get a daily email with more Science stories
Sources

PsyPost - Psychology News • Nov 15, 2026
Common genetic variants matter more in Alzheimer’s than scientists thought